Long-term follow-up of five yr shows superior renal function with everolimus plus early calcineurin inhibitor withdrawal in the PROTECT randomized liver transplantation study-Reference-Cited by-同舟云学术

Long-term follow-up of five yr shows superior renal function with everolimus plus early calcineurin inhibitor withdrawal in the PROTECT randomized liver transplantation study

Published:2016-05-10 Issue:6 Volume:30 Page:741-748
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clin Transplant

Author:

Sterneck Martina¹,Kaiser Gernot M.²³,Heyne Nils⁴,Richter Nicolas⁵,Rauchfuss Falk⁶,Pascher Andreas⁷,Schemmer Peter⁸,Fischer Lutz¹,Klein Christian G.²,Nadalin Silvio⁴,Lehner Frank⁵,Settmacher Utz⁶,Gotthardt Daniel⁸,Loss Martin⁹,Ladenburger Stephan¹⁰,Wimmer Peter¹⁰,Dworak Markus¹⁰,Schlitt Hans J.⁹

Affiliation:

1. Department of Medicine; University Medical Center Hamburg-Eppendorf; Hamburg Germany

2. Department of General, Visceral and Transplantation Surgery; Essen University Hospital; Essen Germany

3. Department of General and Visceral Surgery; St. Bernhard-Hospital Kamp-Lintfort; Kamp-Lintfort Germany

4. Department of General, Visceral and Transplant Surgery; University Hospital Tuebingen; Tuebingen Germany

5. Clinic for General, Abdominal and Transplant Surgery; Hannover Medical School (MHH); Hannover Germany

6. Department of General, Abdominal and Vascular Surgery; Jena University Hospital; Jena Germany

7. Clinic for General, Abdominal and Transplant Surgery; Charité University Medical Center Berlin; Berlin Germany

8. Department of General, Visceral and Transplant Surgery; University Hospital Heidelberg; Heidelberg Germany

9. Department of Surgery; University Hospital Regensburg; Regensburg Germany

10. Novartis Pharma GmbH; Nürnberg Germany

Funder

Novartis Pharma

Publisher

Wiley

Subject

Transplantation

Reference13 articles.

1. Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry;Adam;Liver Transpl,2003

2. Chronic renal failure after transplantation of a nonrenal organ;Ojo;N Engl J Med,2003

3. Renal outcomes after liver transplantation in the model for end-stage liver disease era;Sharma;Liver Transpl,2009

4. The side-effects of ciclosporine-A and tacrolimus;Mihatsch;Clin Nephrol,1998

5. Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology;Nankivell;Transplantation,2004

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. S2k-Leitlinie Lebertransplantation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV);Zeitschrift für Gastroenterologie;2024-09

2. Therapeutic drug monitoring in kidney and liver transplantation: current advances and future directions;Expert Review of Clinical Pharmacology;2024-05-16

3. Long Term Complications of Immunosuppression Post Liver Transplant;Journal of Clinical and Experimental Hepatology;2023-11

4. Tacrolimus—why pharmacokinetics matter in the clinic;Frontiers in Transplantation;2023-08-21

5. Chronic Kidney Disease After Liver Transplantation;Advances in Kidney Disease and Health;2023-07